Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
In a phase II dose-finding trial, semaglutide was evaluated as an anti-obesity medication, demonstrating superior weight loss efficacy when administered once daily subcutaneously compared to both placebo and once-daily 3.0 mg liraglutide in patients with obesity but without T2DM
Product Specifications Quantity: 5mg lyophilized powder Purity: 99%+ HPLC-verified Certificate of Analysis included Women-owned supplier For research and laboratory use only
Always rely on the prescriber, the patient leaflet and trusted sources such as MHRA, NICE and NHS information when making treatment decisions
Romn GC, Mancera-Pez O, Bernal C
US$ 20.13
US$ 24.11
US$ 22.82
US$ 21.67
US$ 25.62
US$ 27.28
US$ 28.55
